Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report.
Medicine (Baltimore)
; 96(21): e6985, 2017 May.
Article
in En
| MEDLINE
| ID: mdl-28538405
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Paclitaxel
/
Carcinoma, Neuroendocrine
/
Albumins
/
ErbB Receptors
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Medicine (Baltimore)
Year:
2017
Type:
Article
Affiliation country:
China